Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SD-101 and Ipilimumab with Radiation in Low-Grade B-Cell Lymphoma
NCT02254772Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of nelitolimod in B cell lymphoma. Started Sep 2014; status: completed.
02
Drugs
nelitolimod
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT02254772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254772.